Tallac Therapeutics on LinkedIn: We're at the Keystone Symposia on

We’re at the Keystone Symposia on B Cells and Tertiary Lymphoid Structures: Emerging Targets in Cancer Therapeutics, where we look forward to discussing…

Immunometabolism: From Mechanisms to Pathways to Therapies

Maria Jose Costa on LinkedIn: Human dendritic cells in cancer

Innate Immunity Across the Molecular, Cellular, Tissue and

Colleen Oliver, MSc

Proximity Based Therapeutics, Keystone Symposia

Tallac Therapeutics Announces Two Abstracts Accepted for

Sponsor Detail Template – Chinese American Biopharmaceutical Society

Tuck Today – Winter 2017 Issue by Tuck School of Business at

Tracy Kuo - Head of Oncology Discovery - Roche

Kelly Tam - Scientist - Pfizer